Fuzi Miklos
Independent Researcher, Seattle, WA, United States.
Front Microbiol. 2025 Apr 10;16:1556656. doi: 10.3389/fmicb.2025.1556656. eCollection 2025.
More than three decades ago multidrug-resistant (MDR) clones of the pathogens: have started to disseminate across wide geographical areas. A characteristic feature of all these MDR lineages is the carriage of some mutations in the quinolone resistance-determining regions (QRDRs) of DNA gyrase and topoisomerase IV which besides conferring resistance to fluoroquinolones are associated with a fitness benefit. Several lines of evidence strongly suggest that extra fitness conferred by these mutations facilitated the dissemination of the international MDR lineages. MDR pathogens require extra energy to cover the fitness cost conferred by the excess antibiotic resistance gene cargo. However, extra energy generated by upgraded metabolic activity was demonstrated to increase the uptake of antibiotics enhancing susceptibility. Accordingly, MDR bacteria need additional positive fitness schemes which, similarly to the QRDR advantage, will not compromise resistance. Some of these, not clone-specific effects are large genomes, the carriage of low-cost plasmids, the transfer of plasmid genes to the chromosome, the application of weak promoters in integrons and various techniques for the economic control of the activity of the integrase enzyme including a highly sophisticated system in These impacts - among others - will confer a fitness advantage promoting the spread of MDR pathogens. However, even the potential of extra fitness generated by the combined effect of various schemes is not without limit and virulence-related genes or less relevant antibiotic resistance gene cargoes will often be sacrificed to permit the acquisition of high-priority resistance determinants. Accordingly major MDR clone strains are usually less virulent than susceptible isolates. In summary, a fitness approach to the research of antibiotic resistance is very useful since the fitness status of MDR bacteria seem to profoundly impact the capacity to disseminate in the healthcare setting.
三十多年前,这些病原体的多重耐药(MDR)克隆开始在广泛的地理区域传播。所有这些MDR谱系的一个特征是,DNA促旋酶和拓扑异构酶IV的喹诺酮耐药决定区(QRDRs)中存在一些突变,这些突变除了赋予对氟喹诺酮类药物的耐药性外,还具有适应性优势。多条证据有力地表明,这些突变赋予的额外适应性促进了国际MDR谱系的传播。MDR病原体需要额外的能量来弥补过多抗生素耐药基因负荷所带来的适应性成本。然而,已证明代谢活性增强产生的额外能量会增加抗生素的摄取,从而增强易感性。因此,MDR细菌需要额外的正向适应性机制,这些机制与QRDR优势类似,不会损害耐药性。其中一些非克隆特异性效应包括大基因组、携带低成本质粒、质粒基因向染色体的转移、整合子中弱启动子的应用以及多种控制整合酶活性的经济技术,包括一个高度复杂的系统。这些影响以及其他影响将赋予适应性优势,促进MDR病原体的传播。然而,即使各种机制的综合作用产生的额外适应性潜力也并非没有限度,与毒力相关的基因或不太相关的抗生素耐药基因负荷通常会被牺牲,以允许获得高优先级的耐药决定因素。因此,主要的MDR克隆菌株通常比敏感菌株的毒力更低。总之,对抗生素耐药性进行适应性研究非常有用,因为MDR细菌的适应性状态似乎对其在医疗环境中的传播能力有深远影响。